Setting Up a Medical-Device Manufacturing or Sterilisation Company in the UAE

Three regulators can each have a say before a device reaches the market. The Emirates Drug Establishment (EDE) administers registration of the device itself, tied to its intended use and risk classification, and to a named legal manufacturer who carries post-market responsibility; this function sat with MOHAP before EDE took it over. The emirate health authority (DHA in Dubai, DOH in Abu Dhabi, or the equivalent elsewhere) licenses the premises where manufacturing, assembly, packaging or sterilisation physically happens, inspecting it as a health-sector establishment rather than an ordinary workshop. MOIAT sits alongside both as the industrial regulator for the facility itself, separate from either health approval.

A company that only imports finished devices and sells them on sits outside this perimeter; that is the subject of a medical-device import and distribution company guide, not this one. The test here is narrower: does the UAE entity change, process, package or sterilise the device before it reaches a patient or clinician, and who is answerable for that step when something goes wrong.

Two obligations recur across the sources this guide draws on, and neither is satisfied by a generic trade licence. First, a device must be registered against its intended use and risk classification before it is placed on the UAE market, and a legal manufacturer must be named as the party accountable for that registration, for post-market vigilance and for any recall. Second, the premises carrying out manufacturing or sterilisation must hold the relevant emirate health authority's facility approval, which is assessed on the process controls in place, not only on the building.

EDE publishes one fee schedule for medical device marketing authorisation: an application fee of AED 100 and AED 5000 for registration, with a stated 45 working days and a certificate valid for five years. Its document list asks for a quality conformity certificate (EC, 510(K) or PMA) matched to Class I, II, III or IV, and the applicant must be a medical warehouse or marketing office licensed by EDE. EDE describes that service as registration for importing and trading, so confirm with EDE how it applies to a UAE entity that manufactures or sterilises. Facility fees, inspection checklists and processing times of the health authorities are not published in a form this guide can cite, so none appear here. Treat facility requirements as what the regulator decides on the specific process, confirmed directly with the relevant emirate health authority. A documented classification and responsibility record (building it is covered under business plans and documentation) is what turns that confirmation into evidence a regulator, bank or customer can act on.

Revenue here usually comes from hospitals, distributors, group purchasing organisations or OEM contracts rather than retail customers, and a bank reviewing the account will want to see which counterparties pay, on what contract basis, and how concentrated the customer list is. Two flows draw particular scrutiny: payments for imported raw materials or sterilant supplies (ethylene oxide and radiation sources among them are controlled rather than ordinary goods) and any pass-through where the UAE entity collects for, or pays out to, an overseas principal manufacturer.

A bank will also expect product-liability insurance and, where the company is the legal manufacturer, evidence of a recall process it could fund and execute. An account opened against forecasts with no classification record, no named legal manufacturer and no insurance arrangement is the most common point at which onboarding stalls.

A foreign manufacturer operating through a UAE entity needs to settle, in writing, who acts as its authorised representative for registration and vigilance, and who is accountable day to day for quality decisions, batch release and a facility inspection. A UAE company holding only a trading licence, with these functions left entirely to staff abroad, will struggle to show the substance a health authority expects of a manufacturing or sterilisation establishment.

Staffing follows from the roles: a quality or regulatory lead, a production supervisor, and (where sterilisation uses a validated method such as ethylene oxide, radiation or steam) a person responsible for that validation, each named before the facility licence is tested, with visas resolved alongside the licence rather than after it.

Most of these share the same root: an activity is named and a licence applied for before the classification and facility questions are settled, so the contract, the insurance and the bank account are all written around an assumption rather than a confirmed position.